Research.Patient.info
Esophagogastric Junction Adenocarcinoma research hub
2 indexed studies · 2 currently recruiting
- recruitingPHASE1
A Phase Ib Trial Evaluating the Safety and Activity of Neoadjuvant Combination of Tislelizumab Plus FLOT for Resectable Esophagogastric Adenocarcinoma
This study is testing a new combination treatment for stomach or gullet cancer that can be removed with surgery. It combines a drug called Tislelizumab with standard chemotherapy (FLOT) given before the operation. We want to see if this new approach is safe and works well.
Germany - recruiting
COGNITION: Genomics-Guided Precision Oncology in Early High-Risk Breast Cancer
This study aims to understand why some breast cancers resist treatment. By looking closely at tumour samples, researchers want to find better ways to match treatments to individual patients, especially those whose cancer doesn't fully respond to standard chemotherapy.
Germany